Old Web
English
Sign In
Acemap
>
authorDetail
>
Inge Dierynck
Inge Dierynck
Immunology
Ritonavir
Virology
HIV-1 protease
Medicine
2
Papers
14
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients.
2014
Journal of Acquired Immune Deficiency Syndromes
Hans-Jürgen Stellbrink
Keikawus Arastéh
Dirk Schürmann
Christoph Stephan
Inge Dierynck
Ilham Smyej
Richard M. W. Hoetelmans
Carla Truyers
Paul Meyvisch
Bert Jacquemyn
Kris Mariën
Kenneth Alan Simmen
Rene Verloes
Show All
Source
Cite
Save
Citations (12)
Safety and pharmacokinetics of the HIV-1 protease inhibitor TMC310911 coadministered with ritonavir in healthy participants: results from 2 phase 1 studies.
2014
Journal of Acquired Immune Deficiency Syndromes
Richard M. W. Hoetelmans
Inge Dierynck
Ilham Smyej
Paul Meyvisch
Bert Jacquemyn
Kris Mariën
Kenneth Alan Simmen
Rene Verloes
Show All
Source
Cite
Save
Citations (2)
1